Compile Data Set for Download or QSAR
Report error Found 3353 of affinity data for UniProtKB/TrEMBL: P35408
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190292(US9180116, 38C)
Affinity DataEC50:  1.40E-7nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190296(US9180116, 39C)
Affinity DataEC50:  0.00000270nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190269(US9180116, 6D)
Affinity DataEC50: <0.00100nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM179834(US9676712, 2C)
Affinity DataEC50:  0.00100nMAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 μl of reduced serum medium containing 0.5% FBS. Place ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50213980(4-(2-((R)-2-((S)-3-hydroxyhept-1-enyl)-5-oxopyrrol...)
Affinity DataEC50:  0.00200nMAssay Description:Agonist activity at EP4 receptor expressed in HEK293 cells assessed as cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190281(US9180116, 28C-H2)
Affinity DataEC50:  0.00290nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM179991(US9676712, 4C)
Affinity DataEC50:  0.00300nMAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 μl of reduced serum medium containing 0.5% FBS. Place ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM179834(US9676712, 2C)
Affinity DataEC50:  0.00700nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 μL of reduced serum medium containing 0.5% FBE. Place ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190271(US9180116, 10C)
Affinity DataEC50:  0.0100nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50101858(4-(2-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-4-(3...)
Affinity DataEC50:  0.0100nMAssay Description:Agonist activity at human EP4 receptor expressed in HEK293T/17 cells assessed as increase in GalphaS-mediated CREB activation measured after 6 to 24 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190275(US9180116, 28C | US9180116, 28H)
Affinity DataEC50:  0.0100nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM179827(US9676712, 1C)
Affinity DataEC50:  0.0140nMAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 μl of reduced serum medium containing 0.5% FBS. Place ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190276(US9180116, 28D | US9180116, 28G)
Affinity DataEC50:  0.0162nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM179986(US9676712, 3C)
Affinity DataEC50:  0.0190nMAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 μl of reduced serum medium containing 0.5% FBS. Place ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50156547(4-(2-((R)-2-((S)-3-hydroxyoct-1-enyl)-5-oxopyrroli...)
Affinity DataEC50:  0.0200nMAssay Description:Agonist activity at human EP4 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50617802(CHEMBL5436415)
Affinity DataEC50:  0.0200nMAssay Description:Agonist activity at EP4 (unknown origin) assessed as increase in calcium fluxMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50373939(CHEMBL258332)
Affinity DataKi:  0.0200nMAssay Description:Displacement of [3H]PGE4 from human EP4 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM35847(DINOPROSTONE | [3H]Prostaglandin E2 | prostaglandi...)
Affinity DataEC50:  0.0200nMAssay Description:Agonist activity at human EP4 receptor expressed in HEK293T/17 cells assessed as increase in GalphaS-mediated CREB activation measured after 6 to 24 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190270(US9180116, 9C)
Affinity DataEC50:  0.0210nMAssay Description:Agonist activity at human EP4 receptor expressed in HEK293T/17 cells assessed as increase in GalphaS-mediated CREB activation measured after 6 to 24 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190269(US9180116, 6D)
Affinity DataEC50:  0.0230nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50373942(CHEMBL272276)
Affinity DataEC50:  0.0300nMAssay Description:Agonist activity at human EP4 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50373939(CHEMBL258332)
Affinity DataEC50:  0.0300nMAssay Description:Agonist activity at human EP4 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190272(US9180116, 12D)
Affinity DataEC50:  0.0350nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190268(US9180116, 2C)
Affinity DataEC50:  0.0380nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190286(US9180116, 36C)
Affinity DataEC50:  0.0380nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM238316(US9394273, 6 | US9394273, 5)
Affinity DataEC50:  0.0400nMpH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2017
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50156551(4-{2-[(2S)-2-[(3R)-3-[3-(4-chloro-2-methylphenyl)p...)
Affinity DataEC50:  0.0400nMAssay Description:Functional activity at human EP4 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50213980(4-(2-((R)-2-((S)-3-hydroxyhept-1-enyl)-5-oxopyrrol...)
Affinity DataEC50:  0.0400nMAssay Description:Agonist activity at human EP4 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190272(US9180116, 12D)
Affinity DataEC50:  0.0470nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50373942(CHEMBL272276)
Affinity DataKi:  0.0500nMAssay Description:Displacement of [3H]PGE4 from human EP4 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM238319(US9394273, 10 | US9394273, 9 | US9394273, 8)
Affinity DataEC50:  0.0500nMpH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2017
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50101822(CHEMBL64804 | PGE2, 15-epi | (Z)-7-[(1R,2R,3R)-3-H...)
Affinity DataEC50:  0.0500nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50617805(CHEMBL5395111)
Affinity DataEC50:  0.0500nMAssay Description:Agonist activity at EP4 (unknown origin) assessed as increase in calcium fluxMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190267(US9180116, 1F)
Affinity DataEC50:  0.0590nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190270(US9180116, 9C)
Affinity DataEC50:  0.0590nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190297(US9180116, 39D)
Affinity DataEC50:  0.0590nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190282(US9180116, 33C)
Affinity DataEC50:  0.0630nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50142481(8-aza-11-deoxyprostaglandin E1 | 7-[(R)-2-((E)-(S)...)
Affinity DataEC50:  0.0650nMAssay Description:Agonist activity at human EP4 receptor expressed in HEK293T/17 cells assessed as increase in GalphaS-mediated CREB activation measured after 6 to 24 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190273(US9180116, 21C)
Affinity DataEC50:  0.0750nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190282(US9180116, 33C)
Affinity DataEC50:  0.0790nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 uL of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190273(US9180116, 21C)
Affinity DataKi:  0.0820nM IC50: 0.220nMpH: 6.0Assay Description:Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190268(US9180116, 2C)
Affinity DataEC50:  0.0880nMAssay Description:Agonist activity at human EP4 receptor expressed in HEK293T/17 cells assessed as increase in GalphaS-mediated CREB activation measured after 6 to 24 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190282(US9180116, 33C)
Affinity DataKi:  0.100nM IC50: 0.280nMpH: 6.0Assay Description:Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50224575((S)-4-(2-(2-(4-(3-bromophenyl)-3-hydroxybutyl)-5-o...)
Affinity DataEC50:  0.100nMAssay Description:Agonist activity at human prostaglandin EP4 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM60734(US9156810, 23/24)
Affinity DataIC50: 44nM EC50:  0.100nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM60734(US9156810, 23/24)
Affinity DataIC50: 29nM EC50:  0.100nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50213978(4-(2-((R)-2-(4-methylocta-1,3-dienyl)-5-oxopyrroli...)
Affinity DataEC50:  0.100nMAssay Description:Agonist activity at EP4 receptor expressed in HEK293 cells assessed as cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM190274(US9180116, 24D)
Affinity DataEC50:  0.110nMT: 2°CAssay Description:1. Seed cells on an EP2 or EP4 STEP plate at a density of 40,000-80,000 cells/well in 200 ul of reduced serum medium containing 0.5% FBS. Place the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2016
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM35847(DINOPROSTONE | [3H]Prostaglandin E2 | prostaglandi...)
Affinity DataKi:  0.110nMAssay Description:Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cell membranes after 120 mins by liquid scintillation counting metho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Cayman Chemical

US Patent
LigandPNGBDBM50335985(N-(1-(4-(4,9-diethoxy-1-oxo-1H-benzo[f]isoindol-2(...)
Affinity DataKi:  0.110nMAssay Description:Antagonist activity at human EP4 receptor expressed in HEK293 cells assessed as PGE2-induced cAMP accumulation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2011
Entry Details Article
PubMed
Displayed 1 to 50 (of 3353 total ) | Next | Last >>
Jump to: